GlaxoSmithKline | GSK
Stock Price
1,342.00
Daily Change
32.50 2.48%
Monthly
-7.32%
Yearly
-5.56%
Q4 Forecast
1,396.61


Peers Price Chg Day Year Date
AbbVie 177.16 5.32 3.10% 27.76% Nov/22
Alcon AG 76.68 0.78 1.03% 18.37% Nov/22
Almirall 8.47 0.18 2.11% 0.89% Nov/22
Amgen 294.64 4.72 1.63% 10.99% Nov/22
argenx SE 582.60 17.80 3.15% 26.30% Nov/22
AstraZeneca 10,474.00 412.00 4.09% 2.95% Nov/22
Bayer 19.80 0.28 1.46% -39.90% Nov/22
Biogen 157.88 -0.16 -0.10% -31.93% Nov/22
Bristol-Myers Squibb 58.86 0.66 1.13% 18.29% Nov/22
Fresenius Medical Care 42.25 0.81 1.95% 16.49% Nov/22
Fresenius 33.31 0.52 1.59% 19.22% Nov/22
Genmab 1,483.50 36.00 2.49% -30.68% Nov/22
Gilead Sciences 90.01 0.40 0.45% 19.41% Nov/22
Galapagos 25.38 1.42 5.93% -25.57% Nov/22
GRIFOLS 10.60 0.20 1.92% -17.61% Nov/22
GlaxoSmithKline 1,342.00 32.50 2.48% -5.56% Nov/22
Hikma Pharmaceutical 1,950.00 78.00 4.17% 11.24% Nov/22
Eli Lilly 747.50 -0.71 -0.09% 24.36% Nov/22
Lonza 521.40 -0.20 -0.04% 48.25% Nov/22
Merck 141.75 3.45 2.49% -11.93% Nov/22
Merck 99.27 -0.86 -0.86% -2.55% Nov/22
Novartis 93.68 2.12 2.32% 8.61% Nov/22
Orion 45.23 0.84 1.89% 21.91% Nov/22
Pfizer 25.66 0.56 2.23% -15.87% Nov/22
Philips 25.22 0.19 0.76% 28.83% Nov/22
Recordati 52.10 1.45 2.86% 16.95% Nov/22
Regeneron Pharmaceuticals 738.00 -5.43 -0.73% -7.55% Nov/22
Roche Holding 254.30 3.20 1.27% 6.69% Nov/22
Sanofi 93.17 2.30 2.53% 8.04% Nov/22
Smith & Nephew 986.80 10.80 1.11% -4.38% Nov/22
UCB 180.00 5.85 3.36% 160.12% Nov/22

Indexes Price Day Year Date
GB100 8262 112.82 1.38% 10.40% Nov/22
EU600 508 5.93 1.18% 10.91% Nov/22

GlaxoSmithKline traded at 1,342.00 this Friday November 22nd, increasing 32.50 or 2.48 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline gained 7.32 percent. Over the last 12 months, its price fell by 5.56 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 1,396.61 by the end of this quarter and at 1,357.18 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.